Trimethoprim
Trimesan is an antibacterial medicine for oral use. The active substance of the medicine is trimethoprim, an inhibitor of dihydrofolate reductase, an enzyme involved in the conversion of dihydrofolate to tetrahydrofolate. Trimethoprim selectively inhibits bacterial protein synthesis, causing their death.
Trimethoprim is effective against most strains of the following microorganisms:
Bordetellasp., Citrobactersp., Enterobactersp., Escherichia coli, Haemophilus influenzae, Hafniasp.,
Klebsiella pneumoniae, Legionellasp., Pasteurellasp., Providenciasp., Serratiasp., Salmonellasp.,
Shigellasp., Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus saprophyticus,
Streptococcus pyogenes, Streptococcus pneumoniae, Streptococcus viridans, Streptococcus faecalis,
Vibriosp., Yersiniasp.
Indications for use:
Urinary tract infections caused by susceptible strains of Escherichia coli, Proteus mirabilis,
Enterobactersp. and staphylococci, including Staphylococcus saprophyticus.
Respiratory tract infections: pneumonia caused by Pneumocystis carinii(including as a complication of acquired immunodeficiency syndrome AIDS).
Gastrointestinal tract infections: typhoid fever, diarrhea caused by E. coli(including traveler's diarrhea).
The sensitivity of microorganisms should be confirmed by tests.
Before starting treatment with Trimesan, the patient should discuss it with their doctor.
Trimethoprim may inhibit blood cell production. If during treatment the patient experiences sore throat, fever, or bruising, they should immediately contact their doctor, as these may be symptoms of bone marrow damage.
The patient should inform their doctor about any existing blood disorders (blood disorders), including anemia, as trimethoprim may worsen their course.
Trimethoprim may potentially cause hyperkalemia (elevated potassium levels in the blood).
Concomitant use of Trimesan with certain medicines (see "Trimesan and other medicines" below), potassium supplements, and foods high in potassium may lead to severe hyperkalemia. Symptoms of severe hyperkalemia may include muscle cramps, irregular heartbeat, diarrhea, nausea, dizziness, or headache.
The patient should inform their doctor about any pre-existing liver or kidney disease, as they may require a dose reduction.
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
In particular, this includes:
See section 3.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.
Pregnant women should not take Trimesan.
Trimethoprim passes into breast milk. It is not recommended to take trimethoprim during breastfeeding.
There is no information that the medicine affects the ability to drive or use machines.
This medicine should always be taken exactly as directed by the doctor. In case of doubts, the patient should consult their doctor or pharmacist.
Usual dose of the medicine:
Adults and children over 12 years: usually 100 mg to 200 mg twice a day (1-2 tablets every 12 hours).
Children between 6 and 12 years: approximately 2 mg to 4 mg per kilogram of body weight (half to 1 tablet), twice a day.
Children under 6 years: the medicine is not recommended for children in this age group.
Tablets can be divided.
The medicine is best taken between meals, as food inhibits trimethoprim absorption.
Duration of treatment:
The medicine should be taken for at least 10 days. After the symptoms of the disease have disappeared, treatment should be continued for another 2 to 3 days.
Patients with renal impairment: dosing depends on the value of creatinine clearance:
In case of creatinine clearance above 30 ml/min, the dose does not differ from the usual dose - 100 mg to 200 mg twice a day.
In case of creatinine clearance between 15-30 ml/min, the dose is 50 mg (half a tablet) every 12 hours.
In patients with creatinine clearance below 15 ml/min, the medicine is not recommended.
Special dosing:
Typhoid fever: initially 300 mg (3 tablets) every 12 hours (for 2-3 days), then 200 mg (2 tablets) every 12 hours.
Pneumocystis pneumonia: 5 mg per kilogram of body weight every 8 hours or 300 mg every 8 hours. In case of combined treatment with a medicine containing dapsone, the dose is 100 mg per day.
In patients who respond to the medicine within the first 72 hours, treatment should be continued for 14 days.
Traveler's diarrhea: 200 mg (2 tablets) every 12 hours.
In case of taking a higher dose of Trimesan than recommended, the patient should immediately consult their doctor or pharmacist.
In case of missing a dose, the patient should take it as soon as possible. They should not take a double dose to make up for the missed dose.
In case of any further doubts about taking this medicine, the patient should consult their doctor or pharmacist.
Like all medicines, Trimesan can cause side effects, although not everybody gets them.
In case of experiencing any of the following serious, life-threatening side effects, the patient should stop taking the medicine and immediately seek medical help (these occur rarely, i.e., less often than in 1 in 1000 patients):
The patient should immediately consult their doctor if they experience any of the following side effects:
of unknown frequency:
Other side effects:
Rarely (occurs less often than in 1 in 1000 patients):
increased levels of potassium, urea, creatinine, bilirubin in the blood, increased activity of liver enzymes, decreased sodium levels in the blood, fever.
Frequency not known (cannot be estimated from available data): discomfort in the upper abdomen, nausea, vomiting, oral mucositis; skin rash, itching, and photosensitivity.
(The frequency of these changes depends on the dose. The rash is often morbilliform and occurs 10-14 days after starting treatment).
If the patient experiences any side effects, including any side effects not listed in the leaflet, they should inform their doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
e-mail: ndl@urpl.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
There are no special precautions for storage of the medicinal product.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Trimesan is a white, round, biconvex tablet with a dividing line on one side.
White, opaque PVC/PVDC/Aluminum blisters in a cardboard box.
Pack size: 20 or 40 tablets
Not all pack sizes may be marketed.
SUN-FARM Sp. z o.o.
ul. Dolna 21
05-092 Łomianki
mibe GmbH Arzneimittel
Münchener Straße 15
06796 Brehna
Germany
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.